Clene stock rallies 52% post-market on MS drug data
https://seekingalpha.com/news/4090283-clene-stock-rallies-post-market-on-ms-drug-data?source=feed_sector_healthcare
Apr 16, 2024 - Clene (CLNN) stock rallied 52% post-market Tuesday after the company presented positive Phase 2 data for its drug CNM-Au8 in the treatment of multiple sclerosis. Read more here.
0
A Once-in-a-Generation Investment Opportunity: 1 Warren Buffett and Cathie Wood Artificial Intelligence (AI) Stock to Buy Hand Over Fist Before It Surges 16%, According to 1 Wall Street Analyst
https://www.fool.com/investing/2024/04/14/a-once-in-a-generation-investment-opportunity-1-wa/?source=iedfolrf0000001
Apr 14, 2024 - Big tech dominates the artificial intelligence (AI) narrative. But one company may be under the radar compared to its peers.
0
Ahead of Morgan Stanley (MS) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
https://www.zacks.com/stock/news/2253844/ahead-of-morgan-stanley-ms-q1-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2253844
Apr 11, 2024 - Beyond analysts' top -and-bottom-line estimates for Morgan Stanley (MS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
0
Pages: 1
Page 1